News
EQS-News: RHÖN-KLINIKUM AG looks back on successful financial year 2023
AEVIS VICTORIA SA (AEVS.SW) – Publication of the Annual Report 2023
EQS-News: STRATEC REPORTS RESULTS FOR 2023 FINANCIAL YEAR
Why Medical Properties Trust Stock Popped Today
Shares of Medical Properties Trust (NYSE: MPW) soared 18.6% on Wednesday after the largest tenant of the healthcare facilities-focused real estate investment trust (REIT) announced a deal to sell
Tufts Medicine and Acadia Healthcare Break Ground on New Behavioral Health Hospital to Serve the Greater Boston Area
Tufts Medicine, a leading Massachusetts integrated, academic health system, and Acadia Healthcare Company, the largest standalone provider of behavioral health services in the U.S., today held a
Why Viking Therapeutics Stock Is Skyrocketing Today
Shares of Viking Therapeutics (NASDAQ: VKTX) had skyrocketed by 25% as of 11:08 a.m. ET on Tuesday. That big gain came after the company announced results from a phase 1 clinical study evaluating an
Viking Therapeutics: Buy, Sell, or Hold?
When it comes to rising stars in biotech, Viking Therapeutics (NASDAQ: VKTX) should probably be one of the first businesses to come to mind today. The company doesn't yet have any sales revenue, but
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
Some investors might remember the obesity drugs developed by Arena Pharmaceuticals and Vivus Pharmaceuticals several years ago. They'll probably also recall that the initial euphoria over those
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever
Few things are more satisfying than watching a steadily growing stream of passive income flow into your brokerage account. If you've been holding back from investing because you think you can't
Cathie Wood Is Selling This High-Yield Dividend Stock. Should You?
Cathie Wood and high dividend yields go together like... well, it's hard to finish that sentence because they don't go together at all. Wood and her Ark Invest funds are known for investing in
Is Viking Therapeutics Stock a Millionaire Maker?
There's no shortage of hype and excitement surrounding Viking Therapeutics (NASDAQ: VKTX) stock these days. The company has a promising weight loss drug candidate in its pipeline at a time when many
1 Magnificent Dividend Stock to Buy and Hold
There are plenty of dividend stocks on the market. However, some raise their payouts irregularly, while others don't have businesses that look robust enough to support payout growth for a long time
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
Price matters. That's true whether we're talking about cars, houses, laptops, or anything else -- including stocks.
Three Motley Fool contributors had price in mind when choosing Axsome Therapeutics
Where Will Viking Therapeutics Stock Be in 10 Years?
Viking Therapeutics (NASDAQ: VKTX) now ranks among the hottest biotech stocks on the market. The company's announcement in February of positive results from its phase 2 study of experimental weight
A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now
Does a rising tide really lift all boats? We could soon find out if the adage applies to the stock market.
A bull market is now well underway. The S&P 500 has soared more than 30% over the last 12
2 High-Yield Dividend Stocks Near 52-Week Lows. Time to Buy the Dips?
Investors looking for stocks that can deliver heaps of passive income might want to turn their heads toward the healthcare sector. Right now, there are a couple of beaten-down stocks offering
Will Pfizer Be a Trillion-Dollar Stock by 2035?
Some investors look at Pfizer (NYSE: PFE) as a has-been. That's understandable in some ways. Sales for the company's once-formidable COVID-19 franchise have tanked. So have Pfizer's overall revenue
3 Stocks I'm Adding to My Retirement Account in March
Whenever I decide on a stock, my mindset is that I'll stay invested in it for nothing short of a decade. Ideally, you're investing in great companies you feel comfortable holding on to until
Could Viking Therapeutics Become the Next Eli Lilly?
Eli Lilly (NYSE: LLY) has become a giant in what may be a $100 billion market a few years from now. I'm talking about the world of weight loss drugs.
Doctors have been prescribing Mounjaro and the
Want Decades of Passive Income? 2 Stocks to Buy Now.
Dividend-paying stocks have generally outperformed those that don't pay dividends over the long term. That's partly because maintaining a healthy dividend requires a solid underlying business. And
EQS-News: MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
Why Illumina Stock Zoomed Higher on Thursday
A legal opinion on the other side of Planet Earth put some juice into Illumina's (NASDAQ: ILMN) stock on Thursday. The gene-sequencing specialist saw its share price rise by over 3%, against the S&P
Bull Market and Beyond: 2 Stocks to Buy and Hold Forever
Investors are enjoying the ongoing bull run. The S&P 500 and Nasdaq Composite recently hit all-time highs. Though that's pretty exciting, bull markets don't last forever. Equities that can perform
EQS-Adhoc: STRATEC PLANS TO DISTRIBUTE DIVIDEND OF € 0.55 PER SHARE FOR 2023 FINANCIAL YEAR
Viking Therapeutics Stock Has 55% Upside, According to 1 Wall Street Analyst
There are potential share price gains, and then there are potential share price gains. In the view of one analyst, Viking Therapeutics (NASDAQ: VKTX) currently stands in front of the latter variety.